Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Oropharyngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 trametinib 5 pembrolizumab 5 selpercatinib 4 dabrafenib 4 Specimen Handling 4 Nivolumab 4 cabozantinib 3 Iodine-131 3 spartalizumab 2 omipalisib 2 lenvatinib 2 durvalumab 2 binimetinib 2 Vemurafenib 2 Sorafenib 2 Ipilimumab 2 Immunoglobulin G 2 Disulfides 2 CTLA-4 Antigen 2 Biopsy 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 tislelizumab 1 tipifarnib 1 sapanisertib 1 relatlimab 1 regorafenib 1 pertuzumab 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Thyroid Neoplasms × Neck Dissection × Clear all

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡